(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[1-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-1,3-dihydro-isoindole-2-carbonyl]-2-methyl-propyl}-succinamic acid

ID: ALA1835321

PubChem CID: 56663393

Max Phase: Preclinical

Molecular Formula: C29H39N5O10

Molecular Weight: 617.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Bioactivity Summary Target Summary Assay Summary

Names and Identifiers

Canonical SMILES: CC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1Cc2ccccc2C1C(=O)N[C@H]1CC(=O)OC1O)C(C)C)C(C)C

Standard InChI: InChI=1S/C29H39N5O10/c1-13(2)22(30-15(5)35)26(40)31-18(10-20(36)37)25(39)33-23(14(3)4)28(42)34-12-16-8-6-7-9-17(16)24(34)27(41)32-19-11-21(38)44-29(19)43/h6-9,13-14,18-19,22-24,29,43H,10-12H2,1-5H3,(H,30,35)(H,31,40)(H,32,41)(H,33,39)(H,36,37)/t18-,19-,22-,23-,24?,29?/m0/s1

Standard InChI Key: KMNYXLBVVHSUPC-FYZKDYHJSA-N

Molfile:

     RDKit          2D

 44 46  0  0  0  0  0  0  0  0999 V2000
   15.5891  -24.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9154  -24.6679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1596  -25.4568    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.9857  -25.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2500  -24.6880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4634  -26.1433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1380  -24.4045    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6052  -23.3671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8528  -23.0232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1918  -21.7105    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8572  -22.1982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4517  -20.9288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0498  -21.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7615  -21.2980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3339  -21.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0498  -22.5355    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4774  -21.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1932  -21.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4774  -22.5355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7615  -22.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1932  -22.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9049  -21.7105    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1932  -20.4730    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6208  -21.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3367  -21.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6208  -20.4730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3367  -22.5355    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3367  -20.0605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0533  -20.4741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3375  -19.2366    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0484  -21.2980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.7642  -21.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4759  -21.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7642  -22.5355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0484  -22.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4759  -22.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4759  -20.4730    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1575  -23.4673    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2758  -20.9294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5258  -21.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3299  -21.8905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8848  -21.2805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6300  -20.4928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8265  -20.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  4  6  2  0
  2  7  1  0
  1  8  1  1
  9  8  1  0
 10 11  1  0
  1  2  1  0
 13 14  1  0
 13 15  1  0
 13 16  2  0
 14 17  1  0
 17 18  1  0
 17 19  1  6
 19 20  1  0
 19 21  1  0
 18 22  1  0
 18 23  2  0
 22 24  1  0
 24 25  1  0
 24 26  1  1
 25 27  2  0
 26 28  1  0
 28 29  1  0
 28 30  2  0
 25 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  6
 34 35  1  0
 34 36  1  0
 33 10  1  0
 33 37  2  0
  2  3  1  0
  9 38  2  0
 11 40  1  0
 39 12  1  0
 39 40  2  0
 12 10  1  0
 40 41  1  0
 11  9  1  0
 41 42  2  0
  3  4  1  0
 42 43  1  0
  4  5  1  0
 43 44  2  0
 44 39  1  0
M  END

Associated Targets(Human)

CASP2 Tchem Caspase-2 (173 Activities)

Discover Target: CASP2

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CASP3 Tchem Caspase-3 (3632 Activities)

Discover Target: CASP3

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 617.66	Molecular Weight (Monoisotopic): 617.2697	AlogP: -0.92	#Rotatable Bonds: 12
Polar Surface Area: 220.54	Molecular Species: ACID	HBA: 9	HBD: 6
#RO5 Violations: 2	HBA (Lipinski): 15	HBD (Lipinski): 6	#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.26	CX Basic pKa: ┄	CX LogP: -1.09	CX LogD: -4.08
Aromatic Rings: 1	Heavy Atoms: 44	QED Weighted: 0.16	Np Likeness Score: 0.21

References

1. Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M, Muñoz-Sanjuán I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C.. (2011) Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors., 19 (19): [PMID:21903398] [10.1016/j.bmc.2011.08.020]
2. Chen, Yi-Hua YH and 9 more authors. 2006-03-09 Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. [PMID:16509578]
3. Maillard, Michel C MC and 17 more authors. 2011-10-01 Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. [PMID:21903398]

(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[1-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-1,3-dihydro-isoindole-2-carbonyl]-2-methyl-propyl}-succinamic acid

Names and Identifiers

Alternative Forms

Associated Targets(Human)

Molecule Features

Drug Indications

Mechanisms of Action

Biocomponents

Calculated Properties

References

Source